Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study.

Chen Z, Triatin RD, Luo L, Snieder H, Schmidt AF, Ditmarsch M, Kastelein JJP, Dullaart RPF, Kuivenhoven JA, Thio CHL

DOI: 10.1186/s12933-026-03209-w
Published: 2026 May 14
Container: Cardiovascular diabetology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12933-026-03209-w,
  title = {Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study.},
  author = {Chen Z and Triatin RD and Luo L and Snieder H and Schmidt AF and Ditmarsch M and Kastelein JJP and Dullaart RPF and Kuivenhoven JA and Thio CHL},
  year = {2026},
  journal = {Cardiovascular diabetology},
  doi = {10.1186/s12933-026-03209-w},
  url = {https://doi.org/10.1186/s12933-026-03209-w}
}

RIS

TY  - JOUR
TI  - Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study.
AU  - Chen Z
AU  - Triatin RD
AU  - Luo L
AU  - Snieder H
AU  - Schmidt AF
AU  - Ditmarsch M
AU  - Kastelein JJP
AU  - Dullaart RPF
AU  - Kuivenhoven JA
AU  - Thio CHL
PY  - 2026
JO  - Cardiovascular diabetology
DO  - 10.1186/s12933-026-03209-w
UR  - https://doi.org/10.1186/s12933-026-03209-w
ER  -

APA

Z, C., RD, T., L, L., H, S., AF, S., M, D., JJP, K., RPF, D., JA, K., & CHL, T. (2026). Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study.. Cardiovascular diabetology. https://doi.org/10.1186/s12933-026-03209-w

Source records

pubmed · retrieved 2026-11-10T15:00:40.076Z